The Signal Transduction Mechanisms of a GPI-anchored Complement Regulatory Protein, CD59.
GPI 锚定补体调节蛋白 CD59 的信号转导机制。
基本信息
- 批准号:08672654
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Many proteins are attached to the cell membranes via glycosyl phosphatidyl anchor rather than by a transmembrane anchor and have no direct contact with the inside of the cells. Despite this, cross-linking of GPI-anchored proteins with antibodies causes activation of T cells and neutrophils. The activation is likely to be mediated through Src kinases. It has been suggested that interaction of the GPI-anchored molecule with kinases requires a transmembrane-transducing element, the identity of which remained controversial.In this study, we focused on a GPI-anchored complement regulatory protein, CD59, as a model, to elucidate the GPI-anchored protein mediating signaling. We identified CD59 associating protein by cross-linking of surface proteins with chemical cross-linker followed by Western blotting with anti-CD59 antibody. The Cd59-associating molecules were estimated to be 13-18 kDa in size. Two-dimensional electrophoresis of the cross-linked products revealed no trace of molecules other than CD59. The cross-linked products showed the same N-terminal sequences as CD59 and a strikingly similar amino acid composition to that of CD59. Thus, most likely, the cross-linked products are CD59 dimers. The finding that CD59 localized on outer membranes is all in the form of dimers suggests the importance of dimerization for CD59 functioning.
许多蛋白质通过糖基磷脂酰锚而不是通过跨膜锚附着于细胞膜,并且与细胞内部没有直接接触。尽管如此,GPI锚定蛋白与抗体的交联引起T细胞和嗜中性粒细胞的活化。这种激活可能通过Src激酶介导。本研究以GPI锚定的补体调节蛋白CD 59为模型,探讨GPI锚定蛋白介导的信号转导机制。我们通过化学交联剂交联表面蛋白,然后用抗CD 59抗体进行Western印迹来鉴定CD 59相关蛋白。Cd 59-缔合分子的大小估计为13-18 kDa。交联产物的二维电泳显示除了CD 59之外没有分子的痕迹。交联产物显示与CD 59相同的N-末端序列和与CD 59惊人相似的氨基酸组成。因此,最有可能的是,交联产物是CD 59二聚体。CD 59定位于外膜上均为二聚体形式的发现表明二聚化对于CD 59功能的重要性。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
鬼木 甫: "インターネットと『創始者特権』の政治経済学" 『大阪学院大学通信』. 28巻・9号. 31-41 (1997)
Oniki, Hajime:“互联网的政治经济学和‘创始人的特权’”《大阪学院大学新闻》,第 28 卷,第 9 期,31-41(1997 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hajime Oniki: "Why did japanese producers perform very well in manufacturing automobiles and electronic appliances during the 1970s and 1980s,but did quite poorly in providing PC and other IT services in the 1990s ?" Paper Presented at the Second Internat
Hajime Oniki:“为什么日本生产商在 1970 年代和 1980 年代在制造汽车和电子电器方面表现出色,但在 1990 年代提供 PC 和其他 IT 服务方面却表现不佳?”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
宮川周士ら: "C5b-8 step lysisi of swine endotherial cells by human complement and functional feature of transfectected CD59." Scand. J. Immunol.43. 361-366 (1996)
Shuji Miyakawa 等人:“人补体对猪内皮细胞的 C5b-8 步裂解和转染 CD59 的功能特征”,J.Immunol.43(1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsumoto, M., Takeda, J., Inoue, N., Tara, T., Hatanaka, M.et al.: "A novel protein that paticipates in nonself discrimination of malignant cells by homologous complement." Nature Med. 3. 1266-1270 (1997)
Matsumoto, M.、Takeda, J.、Inoue, N.、Tara, T.、Hatanaka, M.等人:“一种通过同源补体参与恶性细胞非自我歧视的新型蛋白质。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seya, T., Matsumoto, M., Hatanaka, M., Okada, M., Masaki, T.et al.: "A rapid and efficient purification procedure of human complement receptor type 1 (CR1, CD35)." J.Biochem.Biophys.Methods.32. 69-76 (1996)
Seya, T.、Matsumoto, M.、Hatanaka, M.、Okada, M.、Masaki, T.等人:“一种快速有效的人补体受体 1 型(CR1、CD35)纯化方法。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HATANAKA Michiyo其他文献
HATANAKA Michiyo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HATANAKA Michiyo', 18)}}的其他基金
Mechanisms involved in GPI-anchored-protein signaling dimer formation
GPI 锚定蛋白信号二聚体形成涉及的机制
- 批准号:
10672190 - 财政年份:1998
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms involved in loss of PI-anchored proteins (DAF and CD59) in human leukemia cell lines.
人类白血病细胞系中 PI 锚定蛋白(DAF 和 CD59)丢失的机制。
- 批准号:
05671933 - 财政年份:1993
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Studies on the mechanisms of C9 activation and of C9 inactivation by the regulatory protein(MACIF)
调节蛋白(MACIF)激活C9和失活C9机制的研究
- 批准号:
03671118 - 财政年份:1991
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Characterization of functional synthetic human antibodies specific for the membrane complement regulatory protein CD46
膜补体调节蛋白 CD46 特异性功能性合成人抗体的表征
- 批准号:
300898 - 财政年份:2013
- 资助金额:
$ 1.47万 - 项目类别:
Fellowship Programs
Development of novel therapy for immune-mediated hematological diseases targeted for phagocytosis and complement regulatory protein
开发针对吞噬作用和补体调节蛋白的免疫介导血液疾病的新疗法
- 批准号:
18380186 - 财政年份:2006
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Determination of the active site of the complement regulatory protein CD59
补体调节蛋白CD59活性位点的测定
- 批准号:
06672199 - 财政年份:1994
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
TRANSCRIPTIONAL CONTROL--COMPLEMENT REGULATORY PROTEIN
转录控制——补体调节蛋白
- 批准号:
3456183 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
TRANSCRIPTIONAL CONTROL--COMPLEMENT REGULATORY PROTEIN
转录控制——补体调节蛋白
- 批准号:
2068010 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
TRANSCRIPTIONAL CONTROL--COMPLEMENT REGULATORY PROTEIN
转录控制——补体调节蛋白
- 批准号:
2068009 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
TRANSCRIPTIONAL CONTROL--COMPLEMENT REGULATORY PROTEIN
转录控制——补体调节蛋白
- 批准号:
2068011 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
TRANSCRIPTIONAL CONTROL--COMPLEMENT REGULATORY PROTEIN
转录控制——补体调节蛋白
- 批准号:
3456184 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:














{{item.name}}会员




